BETNESOL 5 mg/100 ml, rectal solution in a bag bag, 100 ml
Active ingredients: Betamethasone, Betamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Solutionbag, 100 mlrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETNESOL 5 mg/100 ml, solution rectale en poche
- Pharmaceutical form
- solution
- Route of administration
- rectale
- Presentation description
- 1 poche(s) polyester polyéthylène copolymère de propylène avec canule(s) de 100 ml
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62421127CIP73010996CIP133400930109960Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEsolution | 5,0 mg · 100 ml de solution rectale | FT |
| PHOSPHATE DISODIQUE DE BÉTAMÉTHASONEsolution | 6,6 mg · 100 ml de solution rectale | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.